EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹1,469 Cr | ₹1,230 Cr | ₹1,181 Cr | ₹1,330 Cr | ₹1,232 Cr |
What is the latest Operating Profit of EMCURE PHARMACEUTICALS ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹1,469 Cr |
| Mar2025 | ₹1,230 Cr |
| Mar2024 | ₹1,181 Cr |
| Mar2023 | ₹1,330 Cr |
| Mar2022 | ₹1,232 Cr |
How is Operating Profit of EMCURE PHARMACEUTICALS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,469 Cr | 19.45 | |
| Mar2025 | ₹1,230 Cr | 4.11 | |
| Mar2024 | ₹1,181 Cr | -11.18 | |
| Mar2023 | ₹1,330 Cr | 7.95 | |
| Mar2022 | ₹1,232 Cr | - | |
Compare Operating Profit of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹42,020.4 Cr | 17.7% | 15.6% | 70% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 17.7% |
15.6% |
70% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses